Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?

被引:130
作者
Brugaletta, Salvatore [1 ,2 ]
Heo, Jung Ho [1 ]
Garcia-Garcia, Hector M. [1 ,3 ]
Farooq, Vasim [1 ]
van Geuns, Robert Jan [1 ]
de Bruyne, Bernard [4 ]
Dudek, Dariusz [5 ]
Smits, Pieter C. [6 ]
Koolen, Jacques [7 ]
McClean, Dougal [8 ]
Dorange, Cecile [9 ]
Veldhof, Susan [9 ]
Rapoza, Richard [10 ]
Onuma, Yoshinobu [1 ]
Bruining, Nico [1 ]
Ormiston, John A. [11 ]
Serruys, Patrick W. [1 ]
机构
[1] Erasmus MC, Intervent Cardiol Dept, Thoraxctr, NL-3015 CE Rotterdam, Netherlands
[2] Univ Barcelona, Dept Cardiol, Thorax Inst, Hosp Clin, Barcelona, Spain
[3] Cardialysis BV, Rotterdam, Netherlands
[4] Cardiovasc Ctr Aalst, Aalst, Belgium
[5] Jagiellonian Univ, Krakow, Poland
[6] Maasstad Hosp, Rotterdam, Netherlands
[7] Catharina Hosp, Eindhoven, Netherlands
[8] Christchurch Hosp, Christchurch, New Zealand
[9] Abbott Vasc, Diegem, Belgium
[10] Abbott Vasc, Santa Clara, CA USA
[11] Auckland City Hosp, Auckland, New Zealand
关键词
VH; ABSORB BVS; Echogenicity; Vasomotion; ATHEROSCLEROTIC PLAQUES; STENT SYSTEM; IMPLANTATION; DYSFUNCTION; ARTERY; MACROPHAGES; AUTOPHAGY; STENOSIS; OUTCOMES; DEVICE;
D O I
10.1093/eurheartj/ehr466
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To analyse the vasoreactivity of a coronary segment, previously scaffolded by the ABSORB bioresorbable vascular scaffold (BVS) device, in relationship to its intravascular ultrasoundvirtual histology (IVUSVH) composition and reduction in greyscale echogenicity of the struts. Coronary segments, transiently scaffolded by a polymeric device, may in the long-term recover a normal vasomotor tone. Recovery of a normal endothelial-dependent vasomotion may be enabled by scaffold bioresorption, composition of the underlying tissue, or a combination of both mechanisms. All patients from the ABSORB Cohort A and B trials, who underwent a vasomotion test and IVUSVH investigation at 12 and 24 months, were included. Acetylcholine (Ach) and nitroglycerin were used to test either the endothelial-dependent or -independent vasomotion of the treated segment. Changes in polymeric strut echogenicitya surrogate for bioresorptionIVUSVH composition of the tissue underneath the scaffold and their relationship with the pharmacologically induced vasomotion were all evaluated. Overall, 26 patients underwent the vasomotion test (18 at 12 and 8 at 24 months). Vasodilatory response to Ach was quantitatively associated with larger reductions over time in polymeric strut echogenicity (y 0.159x 6.85; r 0.781, P 0.001). Scaffolded segments with vasoconstriction to Ach had larger vessel areas (14.37 2.50 vs. 11.85 2.54 mm(2), P 0.030), larger plaque burden (57.31 5.96 vs. 49.09 9.10, P 0.018), and larger necrotic core (NC) areas [1.39 (1.14, 1.74) vs. 0.78 mm(2) (0.20, 0.98), P 0.006] compared with those with vasodilation. Vasodilatory response to Ach, in coronary segments scaffolded by the ABSORB BVS device, is associated with a reduction in echogenicity of the scaffold over time, and a low amount of NC. In particular, the latter finding resembles the behaviour of a native coronary artery not caged by an intracoronary device.
引用
收藏
页码:1325 / 1333
页数:9
相关论文
共 30 条
[1]   Serail In Vivo Intravascular Ultrasound-Based Echogenicity Changes of Everolimus-Eluting Bioresorbable Vascular Scaffold During the First 12 Months After Implantation [J].
Brugaletta, Salvatore ;
Gomez-Lara, Josep ;
Serruys, Patrick W. ;
Farooq, Vasim ;
van Geuns, Robert Jan ;
Thuesen, Leif ;
Dudek, Dariusz ;
Koolen, Jacques ;
Chevalier, Bernard ;
McClean, Dougal ;
Windecker, Stephan ;
Smits, Pieter C. ;
de Bruyne, Bernard ;
Whitbourn, Robert ;
Meredith, Ian ;
van Domburg, Ron T. ;
Sihan, Kenij ;
de Winter, Sebastiaan ;
Veldhof, Susan ;
Miquel-Hebert, Karine ;
Rapoza, Richard ;
Garcia-Garcia, Hector M. ;
Ormiston, John A. ;
Bruining, Nico .
JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (12) :1281-1289
[2]   Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold [J].
Brugaletta, Salvatore ;
Garcia-Garcia, Hector M. ;
Garg, Scot ;
Gomez-Lara, Josep ;
Diletti, Roberto ;
Onuma, Yoshinobu ;
van Geuns, Robert Jan ;
McClean, Dougal ;
Dudek, Dariusz ;
Thuesen, Leif ;
Chevalier, Bernard ;
Windecker, Stephan ;
Whitbourn, Robert ;
Dorange, Cecile ;
Miquel-Hebert, Karine ;
Sudhir, Krishnankutty ;
Ormiston, John A. ;
Serruys, Patrick W. .
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2011, 27 (06) :859-866
[3]   Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study [J].
Brugaletta, Salvatore ;
Garcia-Garcia, Hector M. ;
Diletti, Roberto ;
Gomez-Lara, Josep ;
Garg, Scot ;
Onuma, Yoshinobu ;
Shin, Eun-Seok ;
van Geuns, Robert Jan ;
de Bruyne, Bernard ;
Dudek, Dariusz ;
Thuesen, Leif ;
Chevalier, Bernard ;
McClean, Dougal ;
Windecker, Stephan ;
Whitbourn, Robert ;
Dorange, Cecile ;
Veldhof, Susan ;
Rapoza, Richard ;
Sudhir, Krishnankutty ;
Bruining, Nico ;
Ormiston, John A. ;
Serruys, Patrick W. .
EUROINTERVENTION, 2011, 6 (09) :1110-1116
[4]   Three-dimensional and quantitative analysis of atherosclerotic plaque composition by automated differential echogenicty [J].
Bruining, Nico ;
Verheye, Stefan ;
Knaapen, Michiel ;
Somers, Pamela ;
Roelandt, Jos R. T. C. ;
Regar, Evelyn ;
Heller, Iddo ;
de Winter, Sebstiaan ;
Ligthart, Jurgen ;
Van Langenhove, Glenn ;
de Feijter, Pim J. ;
Serruys, Patrick W. ;
Hamers, Ronald .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2007, 70 (07) :968-978
[5]   Monitoring In Vivo Absorption of a Drug-Eluting Bioabsorbable Stent With Intravascular Ultrasound-Derived Parameters A Feasibility Study [J].
Bruining, Nico ;
de Winter, Sebastiaan ;
Roelandt, Jos R. T. C. ;
Regar, Evelyn ;
Heller, Iddo ;
van Domburg, Ron T. ;
Hamers, Ronald ;
Onuma, Yoshinobu ;
Dudek, Darius ;
Webster, Mark W. I. ;
Thuesen, Leif ;
Ormiston, John A. ;
Cheong, Wai-Fung ;
Miguel-Hebert, Karine ;
Veldhof, Susan ;
Serruys, Patrick W. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (04) :449-456
[6]   Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor [J].
Guba, M ;
von Breitenbuch, P ;
Steinbauer, M ;
Koehl, G ;
Flegel, S ;
Hornung, M ;
Bruns, CJ ;
Zuelke, C ;
Farkas, S ;
Anthuber, M ;
Jauch, KW ;
Geissler, EK .
NATURE MEDICINE, 2002, 8 (02) :128-135
[7]   Interference of Drug-Eluting Stents With Endothelium-Dependent Coronary Vasomotion Evidence for Device-Specific Responses [J].
Hamilos, Michalis ;
Sarma, Jaydeep ;
Ostojic, Miodrag ;
Cuisset, Thomas ;
Sarno, Giovanna ;
Melikian, Narbeh ;
Ntalianis, Argyrios ;
Muller, Olivier ;
Barbato, Emanuele ;
Beleslin, Branco ;
Sagic, Dragan ;
De Bruyne, Bernard ;
Bartunek, Jozef ;
Wijns, William .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (03) :193-200
[8]   Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation [J].
Hofma, SH ;
van der Giessen, WJ ;
van Dalen, BM ;
Lemos, PA ;
McFadden, EP ;
Sianos, G ;
Ligthart, JMR ;
van Essen, D ;
de Feyter, PJ ;
Serruys, PW .
EUROPEAN HEART JOURNAL, 2006, 27 (02) :166-170
[9]   Effects of Statin Treatments on Coronary Plaques Assessed by Volumetric Virtual Histology Intravascular Ultrasound Analysis [J].
Hong, Myeong-Ki ;
Park, Duk-Woo ;
Lee, Cheol-Whan ;
Lee, Seung-Whan ;
Kim, Young-Hak ;
Kang, Duk-Hyun ;
Song, Jae-Kwan ;
Kim, Jae-Joong ;
Park, Seong-Wook ;
Park, Seung-Jung .
JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (07) :679-688
[10]  
Khattab A, 2009, EUROINTERVENTION SF, V5, pF49